208 related articles for article (PubMed ID: 9525609)
1. The impact of multidideoxynucleoside resistance-conferring mutations in human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and error specificity.
Rezende LF; Curr K; Ueno T; Mitsuya H; Prasad VR
J Virol; 1998 Apr; 72(4):2890-5. PubMed ID: 9525609
[TBL] [Abstract][Full Text] [Related]
2. Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.
Drosopoulos WC; Prasad VR
J Virol; 1998 May; 72(5):4224-30. PubMed ID: 9557711
[TBL] [Abstract][Full Text] [Related]
3. Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance.
Das K; Martinez SE; Arnold E
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396546
[TBL] [Abstract][Full Text] [Related]
4. The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
Rezende LF; Drosopoulos WC; Prasad VR
Nucleic Acids Res; 1998 Jun; 26(12):3066-72. PubMed ID: 9611256
[TBL] [Abstract][Full Text] [Related]
5. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.
Shirasaka T; Kavlick MF; Ueno T; Gao WY; Kojima E; Alcaide ML; Chokekijchai S; Roy BM; Arnold E; Yarchoan R
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2398-402. PubMed ID: 7534421
[TBL] [Abstract][Full Text] [Related]
6. The influence of 3TC-resistance mutations E89G and M184V in the human immunodeficiency virus reverse transcriptase on mispair extension efficiency.
Hamburgh ME; Drosopoulos WC; Prasad VR
Nucleic Acids Res; 1998 Oct; 26(19):4389-94. PubMed ID: 9742239
[TBL] [Abstract][Full Text] [Related]
7. Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (-)-beta-D-1',3'-dioxolan guanine.
Feng JY; Myrick F; Selmi B; Deval J; Canard B; Borroto-Esoda K
Antiviral Res; 2005 Jun; 66(2-3):153-8. PubMed ID: 15885814
[TBL] [Abstract][Full Text] [Related]
8. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations.
Maldonado JO; Mansky LM
Viruses; 2018 Jul; 10(7):. PubMed ID: 30029500
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
Ueno T; Shirasaka T; Mitsuya H
J Biol Chem; 1995 Oct; 270(40):23605-11. PubMed ID: 7559526
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.
Tamalet C; Yahi N; Tourrès C; Colson P; Quinson AM; Poizot-Martin I; Dhiver C; Fantini J
Virology; 2000 May; 270(2):310-6. PubMed ID: 10792990
[TBL] [Abstract][Full Text] [Related]
11. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
12. Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro.
Curr K; Tripathi S; Lennerstrand J; Larder BA; Prasad VR
J Gen Virol; 2006 Feb; 87(Pt 2):419-428. PubMed ID: 16432030
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
Shah FS; Curr KA; Hamburgh ME; Parniak M; Mitsuya H; Arnez JG; Prasad VR
J Biol Chem; 2000 Sep; 275(35):27037-44. PubMed ID: 10833521
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
15. Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases.
Álvarez M; Sebastián-Martín A; García-Marquina G; Menéndez-Arias L
Sci Rep; 2017 Mar; 7():44834. PubMed ID: 28333133
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues.
Deval J; Selmi B; Boretto J; Egloff MP; Guerreiro C; Sarfati S; Canard B
J Biol Chem; 2002 Nov; 277(44):42097-104. PubMed ID: 12194983
[TBL] [Abstract][Full Text] [Related]
17. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89.
Tisdale M; Alnadaf T; Cousens D
Antimicrob Agents Chemother; 1997 May; 41(5):1094-8. PubMed ID: 9145875
[TBL] [Abstract][Full Text] [Related]
18. The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.
Mbisa JL; Gupta RK; Kabamba D; Mulenga V; Kalumbi M; Chintu C; Parry CM; Gibb DM; Walker SA; Cane PA; Pillay D
Retrovirology; 2011 May; 8():31. PubMed ID: 21569325
[TBL] [Abstract][Full Text] [Related]
19. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Miranda LR; Götte M; Liang F; Kuritzkes DR
Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
[TBL] [Abstract][Full Text] [Related]
20. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.
Nitanda T; Wang X; Kumamoto H; Haraguchi K; Tanaka H; Cheng YC; Baba M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3355-60. PubMed ID: 16048947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
